-
April 21: The Week in Cancer News
Awareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.
by Eric Fitzsimmons
-
Nudging Our Way to Better Cancer Care
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
April 14: The Week in Cancer News
Treatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.
by Kevin McLaughlin
-
Preventable Emergency Department Visits Trending Upwards for Patients with Cancer
Attentive care can manage conditions that cause patients to seek emergency care, but patients with concerning symptoms should still go to the hospital or urgent care center.
by Sandra Gordon
-
April 7: The Week in Cancer News
New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.
by Thomas Celona
-
Most Cancer Doctors, Patients Interested in Integrative Care
A nationwide survey found strong support for complementary therapies like massage and meditation, but also significant barriers to access.
by Kyle Bagenstose
-
March 31: The Week in Cancer News
Immunotherapies poised to change care in advanced endometrial cancer, and the end of pandemic protection expected to result in loss of health coverage for 15 million people.
by Eric Fitzsimmons
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin